Table 1. Significantly upregulated proteins in the clinical strain compared to ATCC10145 strain.
| RefSep accession | Description | Clinical Isolate SC | ATCC10145 SC | NLOG-FoldR* | Np | Adj-Np |
|---|---|---|---|---|---|---|
| 15596289 |
Flagellin type B |
252 |
12 |
4.0551 |
2.81E-49 |
0.00E+00 |
| 15598888 |
Lipotoxon F, LptF |
158 |
54 |
1.3040 |
2.79E-09 |
0.000002 |
| 15599933 |
Hypothetical protein PA4739 |
138 |
51 |
1.1910 |
2.27E-07 |
0.000139 |
| 116050368 |
Hypothetical protein PA14_33310 |
85 |
8 |
3.0288 |
3.46E-14 |
2.25E-11 |
| 15598887 |
Hypothetical protein PA3691 |
70 |
4 |
3.6003 |
8.69E-14 |
5.65E-11 |
| 15599895 |
Hypothetical protein PA4701 |
66 |
12 |
2.1381 |
4.17E-08 |
0.000026 |
| 116049276 |
Hypothetical protein PA14_47120 |
65 |
4 |
3.4950 |
1.24E-12 |
8.01E-10 |
| 116049954 |
3-hydroxybutyrate dehydrogenase |
50 |
12 |
1.7445 |
0.000030 |
0.016786 |
| 15595257 |
Osmotically inducible protein OsmC |
45 |
11 |
1.7111 |
0.000092 |
0.049631 |
| 15597196 |
Dehydrocarnitine CoA transferase subunit B |
40 |
6 |
2.3227 |
0.000006 |
0.003651 |
| 15597527 |
Hypothetical protein PA2331 |
39 |
3 |
3.0944 |
1.74E-07 |
0.000107 |
| 15600253 |
Polyhydroxyalkanoate synthesis protein PhaF |
33 |
3 |
2.8600 |
0.000004 |
0.002163 |
| 15595792 | Organic solvent tolerance protein OstA | 27 | 1 | 3.5799 | 0.000003 | 0.001770 |
Abbreviations: RefSeq: Reference sequence, SC: scan count, NLOG-FoldR: normalized log ratio, Np: normalized p value, Adj-NP: adjusted normalized p value *Normalized ratios are calculated from the ratio of the scans (clinical/ATCC10145) adjusted to the ratio of the total scans for all proteins detected in each group.